Results 261 to 270 of about 12,793,395 (292)

Chimeric antigen receptor T-cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice

Ca-A Cancer Journal for Clinicians, 2023
Sagar Lonial, Rujul Parikh
exaly  

Tumour Markers in Uraemia: Carbohydrate Antigen CA 72–4, Carcinoembryonic Antigen and Carbohydrate Antigen CA 19–9

Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1996
L, Fernández-Fernández, M, Asensio, E, Tejero, L, Rabadán, L, Lopez   +4 more
openaire   +2 more sources

Clinical value of CA 19-9 (carbohydrate antigen) in gastrointestinal adenocarcinoma.

The Italian journal of surgical sciences, 1985
CA 19-9 and CEA serum levels were determined before and 7 days after surgery in 140 patients with gastrointestinal adenocarcinoma, and in 70 patients with gastrointestinal non neoplastic diseases. CA 19-9 test was shown to be positive in 37.9% of colorectal cancer, in 32.6% of gastric cancer and in 77.8% of pancreatic cancer.
MENNINI, Giuseppe, SILECCHIA, Gianfranco, C. Zanna, G. Cucchiara, G. Spadaro, E. Greco, BASOLI, Antonio, V. Speranza   +7 more
openaire   +2 more sources

CA 19-9 and Lewis Antigens in Pancreatic Cancer

Journal of Clinical Oncology, 2009
openaire   +2 more sources

CA 50 and CA 19-9 antigen expression in normal, hyperplastic, and neoplastic thyroid tissue.

Laboratory investigation; a journal of technical methods and pathology, 1989
The occurrence of the tumor-associated carbohydrate antigens defined by the monoclonal antibodies (moabs) C 50 and 19-9 has been studied by immunoperoxidase staining of formalin-fixed and paraffin-embedded tissue specimens from normal, hyperplastic, adenomatous, and carcinomatous thyroid tissues.
M, Vierbuchen, S, Schröder, G, Uhlenbruck, M, Ortmann, R, Fischer   +4 more
openaire   +1 more source

A guide to antigen processing and presentation

Nature Reviews Immunology, 2022
Hidde Ploegh, Thibault J Harmand, Novalia Pishesha   +2 more
exaly  

Vaccine-boosted CAR T crosstalk with host immunity to reject tumors with antigen heterogeneity

Cell, 2023
Leyuan Ma
exaly  

GPC2-CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicity

Cancer Cell, 2022
Kevin R. Parker, Anya Alag, Crystal Mackall   +2 more
exaly  

Cancer Associated Antigen 19-9 (CA 19-9)

2008
openaire   +1 more source

[Antigens (CEA and CA 19-9) in diagnosis and prognosis colorectal cancer].

Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2002
carcinoembryonic antigen (CEA) was first described more than three decades ago, when its presence was demonstrated in fetal gut tissue and in tumors from gastrointestinal tract. Subsequently, CEA was detected in the circulation of patients and recognized as a serum marker for colorectal cancer.
openaire   +1 more source